The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern ...

There is nothing more inherently unique and personal to an individual than his or her DNA. Unlike many other types of personal information, a ...

Regeneron Pharmaceuticals has bought the genetic testing company 23andMe, a company once valued at $6bn, for $256m through a ...

Regeneron Pharmaceuticals is purchasing nearly all assets of the bankrupt genetic testing company, 23andMe, in a deal worth ...

Regeneron is acquiring “substantially all” of 23andMe’s assets for $256 million following a bankruptcy auction.

Regeneron Pharmaceuticals announced on Monday that it will acquire the genetic testing business and most assets of 23andMe ...

The bankruptcy proceedings of personal genomics and biotechnology company 23andMe risks sensitive information of millions of Americans. The senators highlighted the attempts by the People’s ...

Founded in 2006, 23andMe has collected the genetic information ... Labor and Pensions Committee and the Federal Trade Commission, penned letters voicing concerns that the company’s data ...

Several lawmakers and officials, including the Federal Trade Commission, had expressed concerns about the safety of consumers' genetic data through 23andMe's sale process. The privacy ombudsman ...

The pending sale of millions of customer health records as part of Rite Aid Corp.‘s bankruptcy proceedings is putting a ...